FGFR2 and lung adenocarcinoma: Experiments performed on lung adenocarcinoma cells proposed a bold hypothesis: the N-terminal ankyrin repeats of TRPA1 directly bind to the C-terminal proline-rich motif of the fibroblast growth factor receptor 2 (FGFR2), inducing the activation of the receptor through the MAP kinase pathway [55].